LAUSR

Infective endocarditis (IE) is still associated with high rates of mortality and morbidity despite substantial improvements in medical and surgical management during the last decades. 1 Surgery is primarily recommended for patients presenting with heart failure, extensive valvular and/or paravalvular lesions, and those at high risk of embolism. 2 In this setting, the preferred surgical procedure is debated since surgeons are often faced with a large variety of pathological patterns. Surgical procedures predominantly performed comprise mitral valve repair (MVP) and mitral valve replacement (MVR). MVP is a technically demanding procedure necessitating substantial surgical expertise to preserve the integrity and functionality of the mitral valve. 2,3 The wide armamentarium of currently available MVP techniques makes this surgical procedure feasible even in cases of challenging lesions. 4 However, MVR is performed in cases of irreparable damages of the valve leaflets as well as extensively destructive paravalvular lesions. 2 between for active IE of the decision making for procedure as well the complexities of for regression